Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Surgery
Published in: BMC Surgery 1/2022

Open Access 01-12-2022 | Mastectomy | Research

Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study

Authors: Zijun Zhao, Ting Zhang, Yu Yao, Xin Lu

Published in: BMC Surgery | Issue 1/2022

Login to get access

Abstract

Background

Occult breast cancer (OBC) is a special type of breast cancer. Because of its rarity, clinicopathological information is still insufficient, causing a controversial condition about its treatment recommendation. Thus, we aimed to clarify major clinicopathological information, treatment strategies and prognosis of OBC based on a large population.

Methods

We retrospectively collected adult female OBC population from Surveillance, Epidemiology, and End Results database. We divided the whole cohort into two groups based on surgical treatment in-breast. Descriptive analysis of 18 clinicopathological variables was conducted. Survival analysis was performed based on different clinicopathological factors. Univariate and multivariate Cox regression analysis was performed to identify potential independent predictor for prognosis of OBC.

Results

1189 OBC patients were in final analysis and most of them were diagnosed as an early-stage carcinoma. Patients received breast-conserving treatment (BCT) was nearly two times of ones received mastectomy. Patients receiving radiotherapy in BCT group were significantly more than patients receiving radiotherapy in mastectomy group (61.76 vs. 50.9%, P  <   0.001). After a median follow-up period of 62 months, 5-year and 10-year overall survival (OS) of all subjects was 81.6% and 68.8%, respectively. No significant difference in OS and breast-cancer specific survival (BCSS) was found between mastectomy and local breast-conserving surgery. Older age and larger number of positive lymph nodes causes a worse prognosis whereas radiotherapy brought a better clinical outcome for OBC patients.

Conclusions

OBC has a generally good prognosis. Less-intensive surgery does not negatively impact clinical outcomes of OBC while additional radiotherapy is totally beneficial to prolong OS and BCSS.
Literature
1.
2.
Vlastos G, Jean ME, Mirza AN, et al. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol. 2001;8(5):425–31.CrossRefPubMed
3.
Fayanju OM, Jeffe DB, Margenthaler JA. Occult primary breast cancer at a comprehensive cancer center. J Surg Res. 2013;185(2):684–9.CrossRefPubMed
4.
Zhao KL, Liu Y, Scherpelz KP, et al. Occult primary breast cancer presenting with brachial plexopathy: a case report. SAGE Open Med Case Rep. 2021;9:2050313x20985646.PubMedPubMedCentral
5.
Baron PL, Moore MP, Kinne DW, et al. Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg. 1990;125(2):210–4.CrossRefPubMed
6.
Yang H, Li L, Zhang M, et al. Application of neoadjuvant chemotherapy in occult breast cancer: five case reports. Medicine (Baltimore). 2017;96(40): e8200.CrossRef
7.
Macedo FI, Eid JJ, Flynn J, et al. Optimal surgical management for occult breast carcinoma: a meta-analysis. Ann Surg Oncol. 2016;23(6):1838–44.CrossRefPubMed
8.
Sohn G, Son BH, Lee SJ, et al. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study. J Surg Oncol. 2014;110(3):270–4.CrossRefPubMed
9.
Walker GV, Smith GL, Perkins GH, et al. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer. 2010;116(17):4000–6.CrossRefPubMed
10.
11.
Blanchard DK, Shetty PB, Hilsenbeck SG, et al. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 2008;247(5):732–8.CrossRefPubMed
12.
Olson JA Jr, Morris EA, Van Zee KJ, et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 2000;7(6):411–5.CrossRefPubMed
13.
Varadarajan R, Edge SB, Yu J, et al. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology. 2006;71(5–6):456–9.CrossRefPubMed
14.
15.
Rueth NM, Black DM, Limmer AR, et al. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer. Ann Surg Oncol. 2015;22(1):90–5.CrossRefPubMed
16.
Tsai C, Zhao B, Chan T, et al. Treatment for occult breast cancer: a propensity score analysis of the National Cancer Database. Am J Surg. 2020;220(1):153–60.CrossRefPubMed
17.
He M, Tang LC, Yu KD, et al. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer. Eur J Surg Oncol. 2012;38(11):1022–8.CrossRefPubMed
18.
Wang X, Zhao Y, Cao X. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases. Breast J. 2010;16(1):32–7.CrossRefPubMed
19.
Shannon C, Walsh G, Sapunar F, et al. Occult primary breast carcinoma presenting as axillary lymphadenopathy. Breast. 2002;11(5):414–8.CrossRefPubMed
20.
Masinghe SP, Faluyi OO, Kerr GR, et al. Breast radiotherapy for occult breast cancer with axillary nodal metastases—does it reduce the local recurrence rate and increase overall survival? Clin Oncol (R Coll Radiol). 2011;23(2):95–100.CrossRef
21.
Kim H, Park W, Kim SS, et al. Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI. Breast. 2020;49:63–9.CrossRefPubMed
22.
23.
Kaufmann M, von Minckwitz G, Bear HD, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol. 2007;18(12):1927–34.CrossRefPubMed
24.
Kaufmann M, von Minckwitz G, Mamounas EP, et al. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol. 2012;19(5):1508–16.CrossRefPubMed
Metadata
Title
Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study
Authors
Zijun Zhao
Ting Zhang
Yu Yao
Xin Lu
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2022
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-022-01472-8

Other articles of this Issue 1/2022

BMC Surgery 1/2022 Go to the issue

Case report

Anterolateral thigh flaps in closing large abdominal wall defect after the resection of mucinous adenocarcinoma: a case report

Research

Analysis of the efficacy of the da Vinci robot in surgery for posterior mediastinal neurogenic tumors

Research

A novel method of lateral closing wedge osteotomy for cubitus varus deformity in children

Research

Combined anteroposterior approaches in lateral position treatment of lumbosacral tuberculous in single-stage

Research article

A comparative study of two robotic thyroidectomy procedures: transoral vestibular versus bilateral axillary-breast approach

Research

Comparisons between ankle distraction arthroplasty and supramalleolar osteotomy for treatment of post-traumatic varus ankle osteoarthritis